Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Development and characterization of a double-layered lyophilized carrageenan/polyurethane bioactive dressing loaded with secretome of mesenchymal stem cells for chronic wound healing.

Sadeghi-Avalshahr A., Nazarnezhad S., Noughabi MK., Hassanzadeh H., Namaei-Ghasemnia N., Jalali M.

Laboratory Study on Chronic Wound, Chronic Inflammation, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Int J Biol Macromol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40618822
DOI
10.1016/j.ijbiomac.2025.145725
Citations
1

Abstract (original English)

Non-healing wounds often persist due to ongoing chronic inflammation, bacterial infections, and irregularities in cellular behavior. This study introduces a double-layer bioactive dressing composed of carrageenan, fabricated through a freeze-drying technique. It was hypothesized that incorporating secretome into a carrageenan-based polymeric matrix as a bioactive dressing might enhance various aspects of cellular behavior. The resultant sponge was enriched with a concentrated secretome (858.25 ± 85.73 μg/mL) obtained from adipose-derived mesenchymal stem cells (Ad-MSCs), attached with a semipermeable polyurethane film as a backing layer. The physicochemical results demonstrated that dressing exhibited hydrophilic properties (contact angle of 38.72°), sufficient tensile strength (1.14 MPa), as well as desired swelling ratio and degradation rate. There was a notable improvement in migration of Ad-MSCs in response to secretome treatment within 48 h. Additionally, tube formation by human umbilical vein endothelial cells was significantly enhanced compared to the untreated group. In vitro investigation of inflammation on human dermal fibroblasts (HDF) within a diabetic-like microenvironment demonstrated substantial upregulation of TGF-β, VEGF, and IL-10 expression when treated with the secretome, in comparison to untreated groups. These findings suggest that the developed dressing h

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
PolyurethanesMesenchymal Stem CellsWound HealingHumansCarrageenanFreeze DryingBandagesSecretomeHuman Umbilical Vein Endothelial CellsFibroblasts

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research